You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: VON WILLEBRAND FACTOR: A NEW FLOW MARKER IN CARDIOVASCULAR PATHOLOGY
Reviews
There are no reviews yet.